Biovac's integrated expansion platform — from fill-and-finish to end-to-end drug substance manufacturing. Configure your pathway below.
Biovac's strategic transition from imported drug substance to local end-to-end manufacturing — fermentation, purification, conjugation, formulation, filling, and distribution.
Powered by the BVC Proprietary Cryptographic Ledger. Projected manufacturing timelines are secured by automated compliance routing and zero-latency batch validation. Edge-delivered with SAHPRA Annex 11-aligned data integrity.
Predictive analytics for cleanroom environmental control, cold chain integrity, and bioprocess optimisation. Available with Consortium Dashboard implementation.
Real-time cold chain distribution intelligence across South Africa's nine provinces and six SADC partner countries. GDP-compliant temperature integrity monitoring from Cape Town to the last mile.
Regulatory compliance and quality assurance built into the foundation, turning potential hurdles into milestones.
Our dedicated MSAT team ensures seamless onboarding. We proactively identify regulatory CQAs (Critical Quality Attributes) from day one, designing a process that is robust, scalable, and compliant by design.
Operating under a single, fortified QMS with complete data integrity and batch records ready for regulatory submission (IND, CTA). Our embedded QA team oversees every step, accelerating your path to the clinic.
Facilities built for successful PAI (Pre-Approval Inspection) with ongoing regulatory support for post-market activities, including variation filings and lifecycle management. A true end-to-end partnership.
Speak directly with a partnership expert to architect your definitive project plan with Biovac.